WASHINGTON (AP) — Federal officials have approved another generic version of the abortion pill mifepristone , a regulatory formality that quickly triggered pushback from anti-abortion groups and politicians aligned with the Trump administration.

Drugmaker Evita Solutions announced on its website that the Food and Drug Administration signed off on its low-cost form of the pill , which is approved to end pregnancies through 10 weeks.

See Full Page